SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001144204-12-062054
Filing Date
2012-11-14
Accepted
2012-11-14 10:47:02
Documents
11
Period of Report
2012-09-30
Filing Date Changed
2012-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v326055_10q.htm 10-Q 283829
2 EXHIBIT 31.1 v326055_ex31-1.htm EX-31.1 9989
3 EXHIBIT 31.2 v326055_ex31-2.htm EX-31.2 9997
4 EXHIBIT 32.1 v326055_ex32-1.htm EX-32.1 5061
5 EXHIBIT 32.2 v326055_ex32-2.htm EX-32.2 5170
  Complete submission text file 0001144204-12-062054.txt   2556673

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tglp-20120930.xml EX-101.INS 284469
7 XBRL TAXONOMY EXTENSION SCHEMA tglp-20120930.xsd EX-101.SCH 30934
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tglp-20120930_cal.xml EX-101.CAL 32895
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tglp-20120930_def.xml EX-101.DEF 115087
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tglp-20120930_lab.xml EX-101.LAB 221899
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tglp-20120930_pre.xml EX-101.PRE 155548
Mailing Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038
Business Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038 212-797-9877
Tongli Pharmaceuticals (USA), Inc. (Filer) CIK: 0001052284 (see all company filings)

IRS No.: 841090791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52954 | Film No.: 121201706
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1